HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food ...
HONG KONG, Jan. 5, 2026 /PRNewswire/ — GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food ...
TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...
Dec 18 (Reuters) – U.S. Department of Homeland Security Secretary Kristi Noem said late on Thursday that she has instructed U.S. Citizenship and Immigration Services (USCIS) to pause the DV1 ...
HERE’S JANINE DONALDSON WITH TONIGHT’S EDUCATION ALERT LEARNING HOW TO BE AN ADULT INCLUDES A LOT OF PRACTICAL SKILLS LIKE PAYING BILLS, FIXING THINGS, EVEN SIGNING YOUR NAME. BUT YOU MAY OR MAY NOT ...
CoTx-101 targets retinal vascular diseases using a novel vector, coAAV-SCS, for enhanced retinal penetration and sustained biologic expression. Coave Therapeutics plans to complete non-human primate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback